66748 Results

People

  1. Brennan
    Brennan
  2. Gonen
    Gonen
  3. Vickers
    Vickers
  4. Ladanyi
    Ladanyi
  5. Scher
    Scher
  6. Motzer
    Motzer
  7. Reuter
    Reuter
  8. Jarnagin
    Jarnagin
  9. Fong
    Fong
  10. Antonescu
    Antonescu

Groups

  1. Department of Medicine (19347)
  2. GSK Faculty (13834)
  3. Surgery (13275)
  4. Sloan Kettering Institute Faculty (11206)
  5. Solid Tumor Oncology Division (10831)
  6. Survivorship Research (8900)
  7. Sloan Kettering Institute Postdocs (7820)
  8. Population Sciences Research Program (7144)
  9. Department of Pathology and Laboratory Medicine (6438)
  10. Epidemiology and Biostatistics (6429)
  1. "Journal article"
Formats
  1. Journal Article (66748)
Groups
  1. Department of Medicine (19347)
  2. GSK Faculty (13834)
  3. Surgery (13275)
  4. Sloan Kettering Institute Faculty (11206)
  5. Solid Tumor Oncology Division (10831)
  6. Survivorship Research (8900)

More Groups

People
  1. Murray Brennan (769)
  2. Mithat Gonen (757)
  3. Andrew Vickers (683)
  4. Marc Ladanyi (647)
  5. Howard Scher (624)
  6. Robert Motzer (609)

More People

Years
  1. 2025 (1027)
  2. 2024 (2329)
  3. 2023 (2318)
  4. 2022 (2449)
  5. 2021 (2507)
  6. 2020 (2337)

More Years

Publications
  1. Journal of Clinical Oncology (2143)
  2. Cancer (1294)
  3. Clinical Cancer Research (1174)
  4. Proceedings of the National Academy of Sciences of the United States of America (985)
  5. Blood (938)
  6. Annals of Surgical Oncology (885)

More Publications

Publishers
  1. Elsevier Inc. (7387)
  2. Springer (4153)
  3. Elsevier Science, Inc. (3902)
  4. Lippincott Williams & Wilkins (3828)
  5. Nature Publishing Group (3746)
  6. Wiley Blackwell (3486)

More Publishers

Results (66748)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence and correlates of job and insurance problems among young breast cancer survivors within 18 months of diagnosis
    Journal Article

    Naughton, M. J.; Beverly Hery, C. M.; Janse, S. A.; Naftalis, E. Z.; Paskett, E. D.; Van Zee, K. J.
    BMC Cancer (2020)

    Fulltext@MSK | Save
  • Impact of transcranial direct current stimulation on sustained attention in breast cancer survivors: Evidence for feasibility, tolerability, and initial efficacy
    Journal Article

    Gaynor, A. M.; Pergolizzi, D.; Alici, Y.; Ryan, E.; McNeal, K.; Ahles, T. A.; Root, J. C.
    Brain Stimulation (2020)

    Fulltext@MSK | Save
  • Insulin resistance contributes to racial disparities in breast cancer prognosis in US women
    Journal Article

    Gallagher, E. J.; Fei, K.; Feldman, S. M.; Port, E.; Friedman, N. B.; Boolbol, S. K.; Killelea, B.; Pilewskie, M.; Choi, L.; King, T.; more...
    Breast Cancer Research (2020)

    Fulltext@MSK | Save
  • Two distinct prognostic groups in advanced-stage Hodgkin lymphoma revealed by the presence and site of bulky disease
    Journal Article

    Qi, S.; Milgrom, S.; Dabaja, B.; Tsang, R.; Levis, M.; Ricardi, U.; Lopez-Alonso, R.; Dann, E. J.; Ng, A.; Yahalom, J.
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML
    Journal Article

    Choe, S.; Wang, H.; DiNardo, C. D.; Stein, E. M.; de Botton, S.; Roboz, G. J.; Altman, J. K.; Mims, A. S.; Watts, J. M.; Pollyea, D. A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information
    Journal Article

    Nakajima, R.; Moskowitz, A. J.; Michaud, L.; Mauguen, A.; Batlevi, C. L.; Dogan, A.; Schöder, H.
    Blood Advances (2020)

    Fulltext@MSK | Save
  • A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)
    Journal Article

    Lancet, J. E.; Moseley, A. B.; Coutre, S. E.; DeAngelo, D. J.; Othus, M.; Tallman, M. S.; Litzow, M. R.; Komrokji, R. S.; Erba, H. P.; Appelbaum, F. R.
    Blood Advances (2020)

    Fulltext@MSK | Save
  • A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
    Journal Article

    Schroeder, M. A.; Jean Khoury, H.; Jagasia, M.; Ali, H.; Schiller, G. J.; Staser, K.; Choi, J.; Gehrs, L.; Arbushites, M. C.; Yan, Y.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia
    Journal Article

    Verneris, M. R.; Miller, J. S.; Hsu, K. C.; Wang, T.; Sees, J. A.; Paczesny, S.; Rangarajan, H.; Lee, D. A.; Spellman, S. R.; Lee, S. J.
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 guideline updates on HER2 assessment in breast cancer with equivocal HER2 immunohistochemistry results with focus on cases with HER2/CEP17 ratio <2.0 and average HER2 copy number ≥4.0 and <6.0
    Journal Article

    Hoda, R. S.; Brogi, E.; Xu, J.; Ventura, K.; Ross, D. S.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Wen, H. Y.
    Archives of Pathology & Laboratory Medicine (2020)

    Fulltext@MSK | Save